Delray Medical Center cut the ribbon on its newest high-tech machine last week that targets brain areas to treat movement ...

New expensive but disease-modifying treatments are expected to foster Alzheimer’s disease market growth globally, according to a report. The report by GlobalData, a data and analytics company, showed ...

The lifetime risk of dementia after age 55 is about 42% - more than double the risk reported by earlier studies, and one that puts greater urgency on the need to mitigate addressable health problems, ...

The number of US adults who will develop dementia each year is projected to increase from approximately 514,000 in 2020 to ...

Researchers at New York’s Mount Sinai Hospital have developed a cutting-edge AI-powered algorithm which could aid in the ...

Groundbreaking research reveals potential link between cytomegalovirus (CMV) and Alzheimer's disease, offering new insights ...

Having depression is known to increase a person’s risk of developing dementia, but depression is also an early indicator of ...

Mild chronic small vessel disease, or cerebral small vessel disease (CSVD), is an umbrella term for a range of conditions ...

NDA submitted to U.S. FDA for CAPLYTA® as adjunctive treatment for major depressive disorder; if approved, CAPLYTA® has ...

Gum disease appears to disrupt brain activity, potentially increasing a person’s risk of cognitive decline.People with ...